STOCK TITAN

Inspire Medical Stock Price, News & Analysis

INSP NYSE

Welcome to our dedicated page for Inspire Medical news (Ticker: INSP), a resource for investors and traders seeking the latest updates and insights on Inspire Medical stock.

Inspire Medical Systems Inc. (NYSE: INSP) provides innovative neurostimulation solutions for obstructive sleep apnea (OSA) treatment. This news hub offers investors and healthcare professionals centralized access to official updates, including FDA milestones, clinical trial results, and strategic developments.

Track the company’s progress in advancing minimally invasive therapies through verified press releases, regulatory filings, and market expansion announcements. Key updates include earnings reports, partnership agreements, and advancements in OSA treatment technology.

Discover how Inspire Medical maintains compliance with global medical device standards while delivering clinically validated solutions. Content is organized chronologically for efficient research, with clear sourcing to ensure reliability.

Bookmark this page for real-time updates on INSP’s neurostimulation innovations and their impact on sleep medicine. For comprehensive analysis, combine these primary sources with third-party market commentary available across Stock Titan.

Rhea-AI Summary

Inspire Medical Systems, a medical technology company specializing in innovative, minimally invasive solutions for obstructive sleep apnea, announced its participation in the Jefferies Global Healthcare Conference. Scheduled for June 6, 2024, at 11:30 a.m. Eastern Time, the presentation will be accessible via a live webcast with a replay available for two weeks on Inspire’s Investor website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.13%
Tags
conferences
-
Rhea-AI Summary

Inspire Medical Systems, Inc. reported a 28% year-over-year revenue growth in the first quarter of 2024, reaching $164.0 million. The company expects profitability for the full year 2024, increasing revenue guidance to $783 million to $793 million, reflecting growth of 25% to 27% over 2023. With improved outlook and strong performance, Inspire is optimistic about the remainder of 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-33.47%
Tags
-
Rhea-AI Summary

Inspire Medical Systems, a medical technology company specializing in solutions for obstructive sleep apnea, will present at the BofA Securities 2024 Health Care Conference on May 14, 2024. The presentation will be live-streamed and available for replay on Inspire's Investor website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.8%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.18%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.55%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.86%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.15%
Tags
none

FAQ

What is the current stock price of Inspire Medical (INSP)?

The current stock price of Inspire Medical (INSP) is $130.72 as of July 2, 2025.

What is the market cap of Inspire Medical (INSP)?

The market cap of Inspire Medical (INSP) is approximately 3.9B.
Inspire Medical

NYSE:INSP

INSP Rankings

INSP Stock Data

3.89B
27.83M
2.15%
115.59%
10.58%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GOLDEN VALLEY